Want to learn what’s new in ovarian cancer research and care for 2020? Start here. This fall, we hosted our virtual Uniting for Hope Ovarian Cancer National Conference, where experts in the field presented on a wide range of topics– demystifying genetic testing and precision medicine, providing resources for financial support, explaining clinical trials, and … Continued
The Supreme Court is poised to consider California v. Texas, which will decide the fate of the Affordable Care Act (ACA) — their decision could threaten health coverage for millions of people with pre-existing conditions, including ovarian cancer. OCRA is vigilantly monitoring this upcoming decision, and preparing strategies for addressing any outcomes that may threaten … Continued
There is an 80% recurrence rate when it comes to ovarian cancer, so the question of ‘what next?’ takes on a huge importance. This is the question that Sarah Gitto, PhD, and her team in the Daniel J. Powell Lab at the University of Pennsylvania’s Ovarian Cancer Research Center, have set out to answer. They … Continued
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation. Watch the full FDA listening session in the video below.
It’s been an incredibly busy end of summer/beginning of fall here at OCRA with a double header of Ovarian Cancer Awareness Month and our Uniting for Hope Ovarian Cancer National Conference. We’ve learned so much and strengthened our community. Here are just some of the ways: RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS OCRA HEROES EVENTS WAYS TO … Continued
US Representative Rosa DeLauro (D-CT) is the Chair and founder of the Congressional Ovarian Cancer Caucus. Established in 2015, the Caucus set out to raise awareness of ovarian cancer symptoms and support for research. This was almost a decade after Representative DeLauro helped lead a bipartisan coalition to pass the original Johanna’s Law – also … Continued
What a whirlwind! You heard a lot from us this September, and we want to take just a moment to tell you how grateful we are for your support throughout Ovarian Cancer Awareness Month. With your help, we surpassed our fundraising goal, raising more than $235,000—an incredible achievement that will have a tangible effect in … Continued
It’s time to work out and work toward ovarian cancer cures! Follow along as certified Zumba instructor and OCRA supporter Samantha Schreiber leads you through a high-energy, fun, and impactful session, all to benefit ovarian cancer research. This class is part of our OCRA Heroes Boston series, a weekend of events to raise funds for … Continued
Some well-known people with deeply personal connections to ovarian cancer have echoed what we’ve been saying all September…this disease is a beast. And it doesn’t get talked about enough. Research for better treatments and a cure doesn’t get the funding it deserves. What we all deserve. Listen to what they have to say, and what draws them … Continued
An important victory for the ovarian cancer community came in 2006 when Congress passed Johanna’s Law. What is Johanna’s Law? Also known as The Gynecologic Cancer Education and Awareness Act, the legislation supports a variety of programs, research projects and activities at Centers for Disease Control and Prevention (CDC) aimed at educating healthcare providers and … Continued
In order to understand the complexities of how gene mutations affect an ovarian cancer diagnosis, OCRA-funded researcher Alexander Nikitin, MD, PhD and colleagues looked to see which ones drive, or possibly delay, the onset of the disease. “We found there were various genes that would help the process along, but interestingly, there were other genes … Continued
OCRA’s Uniting for Hope Virtual National Conference is September 29 – October 2 On Tuesday, September 29, we’re kicking off our virtual Ovarian Cancer National Conference, and time is running out to reserve your spot! Worried you can’t commit to four days in front of the computer? We understand. That’s why, for the first time, all of our sessions … Continued
Get email updates about research news, action alerts, and ways to join the fight.
